Merck KGaA Named as a Top Employer by Science Magazine
Merck placed in the top 10 among biotechnology and pharmaceutical companies for the third year in a row
Merck KGaA announced it was named one of the top 10 employers in the biotechnology industry by Science magazine. Merck, including Merck Serono in Geneva, Switzerland, and EMD Serono in the United States, ranked ninth among biotechnology and pharmaceutical companies worldwide. This is the third consecutive year that the company has ranked in the top 10.
“Merck is proud of the environment we foster within our Research and Development teams, where our associates are intellectually curious and thrive on new opportunities,” said Dr. Bernhard Kirschbaum, Executive Vice President Research and Development, Merck Serono. “Our dedication to innovation demonstrates a key component to our success, and we are committed to developing therapies that make a difference in people’s lives.”
The survey yielded responses from 2,444 individuals and ranked companies based on 23 defining characteristics, including corporate image, leadership and direction, work culture/environment and intellectual challenge, among others. Participants came from North America (72%), Europe (22%), and the Pacific Rim (5%). Merck received high scores in the areas of having loyal employees, being socially responsible and doing important, quality research.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents

It all adds up: Study finds forever chemicals are more toxic as mixtures - Research also finds that PFOA and PFOS are major contributors to toxicity
Pituicytoma
Almac partners with Merck KGaA and the MRC to assess markers of response to Cetuximab therapy
Heart_disease

Paper-based test could diagnose Lyme disease at early stages
'Co-conspirator' cells could hold key to melanoma prediction, prevention
Agilent Technologies and French ExonHit Therapeutics to Collaborate - Companies Working to Optimize Microarray Technology for Splice Variant Analysis
InterMed Discovery and Axxam Announce Joint Research Agreement for the Identification of Novel Natural Functional Ingredients

Infection defense: call for support by the killer cells

Innovative microscopy technique reveals secrets of lipid synthesis inside cells - Two-color infrared photothermal microscopy (2C-IPM) opens new avenues for long-term study of lipid metabolism in living cells
